Cellectis
(NASDAQ:CLLS)
$2.56
0.02[0.79%]
At close: Mar 18
$2.56
0[0.00%]
After Hours: 9:05AM EDT

GET A REPORT ON CLLS SENT RIGHT TO YOUR INBOX

37.5%
Overview Rating
Speculative
Technicals Analysis
66
0100
Financials Analysis
20
0100

Cellectis Stock (NASDAQ:CLLS), Quotes and News Summary

Cellectis Stock (NASDAQ: CLLS) stock price, news, charts, stock research, profile.
Open$2.560
Close$2.490
Volume / Avg.24.604K / 62.098K
Day Range2.430 - 2.560
52 Wk Range0.963 - 3.774
Market Cap$183.683M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
41
Short Interest
1.61%
Days to Cover22.67
20%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Ratings
Nov 23
0
0
0
0
0
Strong Buy
Buy
Hold
Sell
Strong Sell
About Cellectis
Sector
Health Care
Industry
Biotechnology
Cellectis SA is a biotechnology company focused on developing immunotherapies for cancer. The compan...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
CLLS
SYRS

FAQ

Q

How do I buy Cellectis (CLLS) stock?

A

You can purchase shares of Cellectis (NASDAQ: CLLS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Cellectis's (CLLS) competitors?

Q

What is the target price for Cellectis (CLLS) stock?

A

The latest price target for Cellectis (NASDAQ: CLLS) was reported by JMP Securities on Wednesday, November 1, 2023. The analyst firm set a price target for 6.00 expecting CLLS to rise to within 12 months (a possible 134.38% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Cellectis (CLLS)?

A

The stock price for Cellectis (NASDAQ: CLLS) is $2.56 last updated March 18, 2024 at 9:05 AM EDT.

Q

Does Cellectis (CLLS) pay a dividend?

A

There are no upcoming dividends for Cellectis.

Q

When is Cellectis (NASDAQ:CLLS) reporting earnings?

A

Cellectis’s Q1 earnings are confirmed for Thursday, May 2, 2024.

Q

Is Cellectis (CLLS) going to split?

A

There is no upcoming split for Cellectis.

Q

What sector and industry does Cellectis (CLLS) operate in?

A

Cellectis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch